Table 2.
Control | Non-metastatic primary | Other-metastatic primary | Brain-metastatic primary | Brain metastases |
---|---|---|---|---|
2/15 (13.3%) | 5/15 (33.3%) | 9/15 (60%) | 8/10 (80%) | 7/8 (83.33%) |
Control | Non-metastatic primary | Other-metastatic primary | Brain-metastatic primary | Brain metastases |
---|---|---|---|---|
2/15 (13.3%) | 5/15 (33.3%) | 9/15 (60%) | 8/10 (80%) | 7/8 (83.33%) |